International Conference on Biomarkers and Radiology in Cancer

This track focuses on the latest developments in MRI and computed tomography imaging technologies for cancer diagnosis. It aims to explore their applications in enhancing the accuracy and efficacy of cancer detection.

This session will delve into the advancements in positron emission tomography (PET) imaging, particularly in its integration with CT and MRI. Participants will discuss the implications of hybrid imaging techniques on cancer diagnosis and treatment planning.

This track will investigate the role of biomarkers in the early detection and management of breast and lung cancers. Emphasis will be placed on the identification of novel biomarkers and their potential for personalized treatment strategies.

This session will explore the significance of biomarkers in the diagnosis and treatment of prostate and blood cancers. Discussions will include the latest research findings and their implications for clinical practice.

This track will focus on the discovery and validation of biomarkers specific to colorectal and ovarian cancers. The session aims to highlight their potential in improving patient outcomes through targeted therapies.

This session will examine the rationale behind targeted therapies and immunotherapy in cancer treatment. Participants will discuss the latest evidence supporting their use and the challenges faced in clinical implementation.

This track will address the integration of radiotherapy with novel therapeutic strategies, including immunotherapy and targeted treatments. The focus will be on optimizing treatment regimens to enhance patient outcomes.

This session will explore the mechanisms and clinical applications of androgen manipulation and T-cell modulation in cancer therapy. Discussions will include their roles in improving treatment efficacy and patient survival.

This track will investigate the immune biological properties of human cancer stem cells and their implications for cancer treatment. Participants will discuss potential therapeutic targets and strategies for overcoming resistance.

This session will focus on novel phosphatidyl service targeting and bite antibodies in cancer immunotherapy. The aim is to explore their applications in treating solid tumors and enhancing immune responses.

This track will examine strategies for targeting the myeloma microenvironment using immunotherapy. Discussions will focus on the challenges and opportunities in developing effective treatments for myeloma patients.